Stock Compensation (Tables)

12 Months Ended

Feb. 28, 2018

ctivity for non-vested restricted stock unit awards for the year ended February 28, 2018 is as follows:



	Restricted Stock Units		Weighted Average Grant Date Fair Value
Non-Vested Balance as of February 28, 2017	134,547		$	51.10
Granted	46,436		60.01
Vested	(62,576	)	47.26
Forfeited	(8,630	)	56.64
Non-Vested Balance as of February 28, 2018	109,777		$	56.62

A summary of the Company’s stock appreciation rights awards activity is as follows:



	Year Ended
	February 28, 2018				February 28, 2017				February 29, 2016
	SARs		Weighted Average Exercise Price		SARs		Weighted Average Exercise Price		SARs		Weighted Average Exercise Price
Outstanding at beginning of year	170,139		$	42.02	312,748		$	34.23	376,982		$	31.27
Granted	—		—		—		—		—		—
Exercised	(19,481	)	31.94		(141,983	)	24.85		(59,441	)	14.67
Forfeited	(2,145	)	45.36		(626	)	43.92		(4,793	)	44.56
Outstanding at end of year	148,513		$	43.29	170,139		$	42.02	312,748		$	34.23
Exercisable at end of year	148,513		$	43.29	126,975		$	41.27	217,961		$	29.83

The following table summarizes additional information about stock appreciation rights outstanding at February 28, 2018.



Range of Exercise Prices	Total SARs	Average Remaining Life	Weighted Average Exercise Price		SARs Currently Exercisable	Weighted Average Exercise Price
$25.67	9,080	1.00	$	25.67	9,080	$	25.67
$39.65	950	2.52	$	39.65	950	$	39.65
$43.92	82,378	3.01	$	43.92	82,378	$	43.92
$45.26	40,000	2.68	$	45.26	40,000	$	45.26
$45.36	16,105	2.00	$	45.36	16,105	$	45.36
$25.67 - $45.36	148,513	2.68	$	43.29	148,513	$	43.29

Share-based compensation expense and related income tax benefits related to all the plans listed above were as follows (in thousands):